Top Buy
| Security | Buy | Sell | Buy (1M) ▲ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Sarepta Therapeutics | 1 | 0 | 0 | 0 | €117.60 | €130.00 | 10.544% |
| Vericel Corp. | 1 | 0 | 0 | 0 | €44.60 | - | - |
| Virbac S.A. | 1 | 0 | 0 | 0 | €356.00 | - | - |
| Avadel Pharmaceuticals plc ADR | 1 | 0 | 0 | 0 | €15.10 | €23.00 | 52.318% |
| Brainstorm Cell | 1 | 0 | 0 | 0 | €0.57 | - | - |
| Avid Bioservices Inc | 2 | 0 | 0 | 0 | €8.10 | €10.00 | 23.457% |
| GSK plc | 1 | 0 | 0 | 0 | €20.92 | - | - |
| Valneva SE | 2 | 0 | 0 | 0 | €3.89 | €7.00 | 79.764% |
| UCB S.A. | 2 | 0 | 0 | 0 | €129.10 | - | - |
| Viatris Inc. | 1 | 0 | 0 | 0 | €9.82 | - | - |
| Ipsen S.A. | 1 | 0 | 0 | 0 | €123.40 | - | - |
| Innoviva Inc. | 3 | 0 | 0 | 0 | €14.70 | €30.00 | 104.082% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €68.10 | €65.00 | -4.552% |
| Vanda Pharmaceuticals | 4 | 0 | 0 | 0 | €4.52 | €5.00 | 10.619% |
| QIAGEN NV | 9 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| Merck KGaA | 3 | 1 | 0 | 0 | €167.45 | €146.00 | -12.810% |
| Grifols S.A. | 1 | 0 | 0 | 0 | €9.07 | - | - |
| Adocia | 1 | 0 | 0 | 0 | €9.20 | €20.00 | 117.391% |
| Nektar Therapeutics | 3 | 1 | 0 | 0 | €1.56 | €3.70 | 137.028% |
| Perrigo Co. plc | 3 | 0 | 0 | 0 | €26.10 | €35.99 | 37.875% |
| Aveo Pharmaceuticals Inc. | 1 | 0 | 0 | 0 | €13.85 | €100.00 | 622.022% |